Literature DB >> 3941848

Reanimation of the long-standing partial facial paralysis.

L R Rubin, G W Lee, R L Simpson.   

Abstract

Those unfortunate people who suffer from permanent partial facial paralysis have great difficulty finding surgeons who can offer corrective operations. Improving their function is a most delicate procedure. Great care must be exercised to avoid injuring nerves and muscles which are still operating, although in a greatly diminished state. The pathogenesis must be understood before attempting any corrective procedure. Adequate time must elapse from the moment of injury to surgical intervention, thus allowing for maximal nerve and muscle regeneration. This paper describes techniques that could improve facial movements. The most frequently used procedure is shortening of the levator and/or the zygomatic muscles that are partially atrophied. It must be understood that total reanimation is impossible as of this time.

Entities:  

Mesh:

Year:  1986        PMID: 3941848     DOI: 10.1097/00006534-198601000-00008

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  5 in total

1.  Facial reinnervation after facial paralysis: is it ever too late?

Authors:  N B Gagnon; P Molina-Negro
Journal:  Arch Otorhinolaryngol       Date:  1989

2.  An unusual cause of lagophthalmos.

Authors:  G I Nambi; B Beck; A K Gupta
Journal:  Oman J Ophthalmol       Date:  2010-01

3.  Low-level versus high-level placement of gold plates in the upper eyelid in patients with facial palsy.

Authors:  Tarek A Amer; Hisham M El-Minawi; Malak I El-Shazly
Journal:  Clin Ophthalmol       Date:  2011-06-30

4.  Custom-made Gold Implant for Management of Lagophthalmos: A Case Report.

Authors:  Suleyman Hakan Tuna; Hasan Onder Gumus; Nur Hersek
Journal:  Eur J Dent       Date:  2008-10

5.  A Bidimensional System of Facial Movement Analysis Conception and Reliability in Adults.

Authors:  Marjolaine Baude; Emilie Hutin; Jean-Michel Gracies
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.